Cancer Cell ASXL 1 Loss Inhibits PRC 2 in Myeloid Leukemia syndrome and z 10 % – 15 % of patients with myeloproliferative neoplasms and acute myeloid leukemia
暂无分享,去创建一个
Jacob D. Jaffe | B. Bernstein | Mazhar Adli | O. Abdel-Wahab | A. Melnick | M. Carroll | R. Koche | R. Levine | A. Shih | S. Nimer | I. Aifantis | Xinyang Zhao | Christopher Y. Park | Jay P. Patel | F. Perna | Jordan E. Taylor | Suveg Pandey | Y. R. Chung | Todd Hricik | Jie Gao | Lindsay M. LaFave